
ACIP issued an interim recommendation to the Janssen COVID-19 vaccine for use in individuals aged ≥18 years for the prevention of COVID-19.

ACIP issued an interim recommendation to the Janssen COVID-19 vaccine for use in individuals aged ≥18 years for the prevention of COVID-19.

COVID-19 antibody test may also be able to identify those who have been exposed to the disease but have so far been asymptomatic.

Published: February 4th 2021 | Updated:

Published: March 3rd 2021 | Updated: